Study Assessing Safety and Efficiency of the Lenalidomide and Dexamethasone Combination in Patients With Chronic Lymphatic Leukemia (CLL) Relapsing or Resistant to Treatment

NCT01246557 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Chronic Lymphatic Leukemia

Interventions

DRUG: Lenalidomide
DRUG: Dexamethasone

Sponsor

Hospital Universitari Vall d'Hebron Research Institute